Medication for management of pregnancy-induced hypertension

Por um escritor misterioso
Last updated 07 novembro 2024
Medication for management of pregnancy-induced hypertension
Hypertension refers to increased arterial blood pressure and can be divided into two categories: primary and secondary. Primary hypertension caused by angiogenic degenerative changes is a degenerative disease. With liberalization of China’s reproduction policy and increases in maternal age, the prevalence of pregnancy-induced hypertension (PIH) in China has increased gradually. PIH is not a type of primary hypertension, but there are differences in the treatment of these two types of hypertension. Here, we review the choice and use of drugs for PIH management using drugs for the management of primary hypertension as a reference. First-line drugs such as labetalol, nifedipine, or methyldopa should be taken via the oral route if blood pressure is ≥ 150/90 mmHg. For chronic hypertension, other drugs should be added after the first drug at the highest concentration has been revealed to be ineffective. If the blood pressure of patients with acute hypertension is ≥ 160/110 mmHg, maternal stroke or eclampsia can result. If PIH patients are about to deliver, they can be given labetalol (i.v.), hydralazine (i.v.) or nifedipine (p.o.). Moreover, all anti-hypertensive treatments should be based on considerations of maternal and fetal safety.
Medication for management of pregnancy-induced hypertension
PDF) Correlates on the Knowledge and Management Practices on Pregnancy Induced Hypertension (PIH) Among Women in Northern Philippines
Medication for management of pregnancy-induced hypertension
Lesson: Review of Hypertension in Pregnancy for Pharmacists
Medication for management of pregnancy-induced hypertension
Hypertensive Disorders of Pregnancy and Future Maternal Cardiovascular Risk
Medication for management of pregnancy-induced hypertension
JCM, Free Full-Text
Medication for management of pregnancy-induced hypertension
Frontiers Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum
Medication for management of pregnancy-induced hypertension
Summary of Clinical Practice Guidelines on BP Treatment Thresholds and
Medication for management of pregnancy-induced hypertension
Management of Women With Acquired Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 3/5
Medication for management of pregnancy-induced hypertension
Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance
Medication for management of pregnancy-induced hypertension
Hypertensive disorders of pregnancy: definition, management, and out-of-office blood pressure measurement
Medication for management of pregnancy-induced hypertension
Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets - The Lancet Diabetes & Endocrinology
Medication for management of pregnancy-induced hypertension
Severe hypertension in pregnancy
Medication for management of pregnancy-induced hypertension
Study shows treating preexisting high blood pressure in pregnancy improves maternal and fetal outcomes - News
Medication for management of pregnancy-induced hypertension
Guideline No. 426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and Management - Journal of Obstetrics and Gynaecology Canada

© 2014-2024 blog.nationbloom.com. All rights reserved.